Teijin, Takeda Accuse Lupin Of Infringing Uloric Patent
Japanese drugmakers Teijin Ltd. and Takeda Pharmaceuticals Co. Ltd. sued Indian rival Lupin Ltd. in Delaware federal court Wednesday, accusing it of infringing a Teijin-owned patent with its planned generic version...To view the full article, register now.
Already a subscriber? Click here to view full article